Podcast

June 30, 2019

Podcast: This Week in Managed Care—Hospital Pricing Transparency and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care^® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included President Trump issuing an executive order for more healthcare transparency; provisional data indicating that overdose deaths may be falling; the Supreme Court agreeing to hear insurers' Affordable Care Act lawsuit.

Listen above or through one of these podcast services:

Trump Issues Executive Order Intended to Require Disclosure of Negotiated Rates Between Insurers, Hospitals

Provisional Data Predict Overdose Death Rates Will Fall for First Time in Decades

What We're Reading: Supreme Court to Hear ACA Suit; Missouri Abortion Clinic; City of Hope Investment

Nearly 5.4 Million Cancer Survivors Suffer From Chronic Pain

MIT Group Brings Together Stakeholders to Brainstorm How to Pay for Curative Therapies Over Time

Two-Sided Risk in the Oncology Care Model

NCCN's Putnam Serving as Point of Contact for Payers, Employers to Keep Cancer Care "Accessible"

Evidence-Based Oncology—June 2019

Read more about the stories in this podcast:

Related Videos

Milind Desai, MD

Masanori Aikawa, MD

Cesar Davila-Chapa, MD

Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com

Krunal Patel, MD

Juan Carlos Martinez, MD

Rachel Dalthorp, MD

dr joseph alvarnas

dr jennifer green

Related Content

Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com

November 21st 2024

Semaglutide Eligibility Expands to Over Half of US Adults

Cameron Santoro

Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.

Managed Care Cast

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

New research sheds light on the impact of neuronal deficits in SMA | image credit: Muhammed - stock.adobe.com

November 21st 2024

Neuronal Deficit in Severe Infantile SMA Broader Than Previously Thought, Study Finds

Jared Kaltwasser

New research suggests previous assumptions about the pathogenesis of spinal muscular atrophy (SMA) are inadequate.

October 24th 2024

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.

Patient in the hospital - Tyler Olson -stock.adobe.com.jpg

November 20th 2024

New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease

Giuliana Grossi

Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.

Cybersecurity. | Image credit: Gorodenkoff - stock.adobe.com

November 20th 2024

2025 Outlook: Tackling AI, Cybersecurity, and Regulatory Challenges

This is how health care organizations are addressing compliance pressures, cybersecurity threats, and the rise of artificial intelligence (AI) amid resource constraints and evolving regulations.

Related Content

Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com

November 21st 2024

Semaglutide Eligibility Expands to Over Half of US Adults

Cameron Santoro

Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.

Managed Care Cast

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

New research sheds light on the impact of neuronal deficits in SMA | image credit: Muhammed - stock.adobe.com

November 21st 2024

Neuronal Deficit in Severe Infantile SMA Broader Than Previously Thought, Study Finds

Jared Kaltwasser

New research suggests previous assumptions about the pathogenesis of spinal muscular atrophy (SMA) are inadequate.

October 24th 2024

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.

Patient in the hospital - Tyler Olson -stock.adobe.com.jpg

November 20th 2024

New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease

Giuliana Grossi

Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.

Cybersecurity. | Image credit: Gorodenkoff - stock.adobe.com

November 20th 2024

2025 Outlook: Tackling AI, Cybersecurity, and Regulatory Challenges

This is how health care organizations are addressing compliance pressures, cybersecurity threats, and the rise of artificial intelligence (AI) amid resource constraints and evolving regulations.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions